Safety and efficacy assessment of Chungpyesagan-tang for acute ischemic stroke

American Journal of Chinese Medicine

Volumn 31, Issue 2, 2003, Pages 181-190

  Jung, Woo Sang ^a   Choi, Dong Jun ^a   Cho, Ki Ho ^a   Lee, Kyung Sup ^a   Moon, Sang Kwan ^a   Kim, Young Suk ^a   Bae, Hyung Sup ^a   Choi, Byung Ok ^b  

^a Kyung Hee University   (South Korea)

^b CHA University   (South Korea)

Author keywords

Chungpyesagan tang; Stroke

Indexed keywords

CHINESE DRUG; CHUNGPYESAGAN TANG; UNCLASSIFIED DRUG; CHUNGPYESAGAN-TANG; HERBACEOUS AGENT;

ACUTE DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; TREATMENT OUTCOME; AGED; ALGORITHM; BRAIN INFARCTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ACUTE DISEASE; AGED; ALGORITHMS; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0041818423     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X03000898     Document Type: Article

References (30)

1. Adams, H.P. Jr., P.H. Davis, E.G. Leira, K.C. Chang, B.H. Bendixen, W.R. Clarke, R.F. Woolson and M.D. Hansen. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53(1): 126-131, 1999.
2. Arao, T., J. Kinjo, T. Nohara and R. Isobe. Oleanene-type triterpene glycosides from puerariae radix. IV. Six new saponins from Pueraria lobata. Chem. Pharm. Bull. (Tokyo) 45: 362-366, 1997.
3. Brott, T., H.P. Jr. Adams, C.P. Olinger, J.R. Marler, W.G. Barson, J. Biller, J. Spilker, R. Holleran, R. Eberle and V. Hertzberg. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 23(6): 864-870, 1989.
4. Brown, R.D., J.P. Whinsnant, J.D. Sicks, W.M. O'Fallon and D.O. Wiebers. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 27(3): 373-380, 1996.
5. Chen, J.W. Effects of Rhizoma Ligustici chuanxiong and allopurinol on ischemia-reperfusion damage of rabbit ear flap. Chung Hua Wai Ko Tsa Chih 31(5): 312-314, 1993.
6. Chicaud, P., J.R. Rademakers and J. Millet. The beneficial effect of abeta-D-xyloside, Iliparcil, in the prevention of postthrombolytic rethrombosis in the rat. Haemostasis 28(6): 313-320, 1998.
7. de Haan, R., M. Limburg, J. Schuling, J. Broeshart, L. Jonkers and P. van Zuylen. Clinimetric evaluation of the Barthel Index, a measure of limitations in daily activities. Nederlands Tijdschrift voor Geneeskunde 137(18): 917-921, 1993.
8. Engberg, A., L. Bentzen and B. Garde. Rehabilitation after stroke: predictive power of Barthel Index versus a cognitive and a motor index. Acta Neurol Scand. 91(1): 28-36, 1995.
9. Goldstein, L.B. and G.P. Samsa. Reliability of the National Institutes of Health Stroke Scale: extension to non-neurologists in the context of a clinical trial. Stroke 28: 307-310, 1997.
10. Gorshkova, I.A., V.I. Kalinin, B. A. Gorshkov and V.A. Stonik. Two different modes of inhibition of the rat brain Na+, K(+)-ATPase by triterpene glycosides, psolusosides A and B from the holothurian Psolus fabricii. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 122(1): 101-108, 1999.
11. Higuchi, Y., K. Yamashita, K. Taniyama, M. Satake and M. Ozaki. Shichimotsu-koka-to prevent stroke and changes free-radical-related enzyme in stroke-prone spontaneously hypertensive rats (SHRSP). Nippon Yakurigaku Zasshi 108(1): 13-22, 1996.
12. Keji, C. and S. Jun. Progress of research on ischemic stroke treated with Chinese medicine. J. Trad. Chin. Med. 12(3): 204-210, 1992.
13. Kim, D.R., B.H. Ko and I.B. Song. An experimental study of the effect by Chongshimyonjatang and Chongpyesagantang of immune response and anti-allergic reaction to rats and mice. Kyung-Hee Univ. Orient. Med. J. 14: 131-160, 1991.
14. Kim, J.D., H.S. Bae, K.H. Joh, Y.S. Kim, K.S. Lee, E.K. Park, E.A. Bae and D.H. Kim. Scientific analysis of the formulation theory of Chungpesagan-tang: in vitro cytotoxicity of Chungpesagan-tang. Nat. Prod. Sci. 6(1): 25-30, 2000.
15. Kim, J.J., H.J. Kim, B.K. An, W.S. Hong, W.H. Kim, S.I. Lee, H.I. Lee, E.K. An, M.K. Sin, J.J. Moon and K.H. Kim. Studies on the therapeutics for liver disease in herb remedies: experimental study on the effect of Chungpesakan-tang. Kyung-Hee Univ. Orient. Med. J. 1: 9-13, 1978.
16. Kim, Y.S., S.K. Moon, C.N. Ko, K.H. Joh, H.S. Bae and K.S. Lee. A comparison between stroke patients admitted to Oriental hospital in the years 1987 and 1994. In Excerpt of 9th ICOM, 1998, pp. 418-455.
17. Kimura, Y., K. Yokoi, N. Matsushita and H. Okuda. Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. J. Pharm. Pharmacol. 49(8): 816-822, 1997.
18. Koeda, M., Y. Aoki, N. Sakurai and M. Nagai. Studies on the Chinese crude drug "shoma." IX. Three novel cyclolanostanol xylosides, cimicifugosides H-1, H-2 and H-5, from cimicifuga rhizome. Chem. Pharm. Bull. (Tokyo) 43(5): 771-776, 1995.
19. Kwon, D.Y, K.H. Cho, S.K. Moon, C.N. Ko, Y.S. Kim, H.S. Bae and K.S. Lee. Sympromatic indications of Chungpesagan-tang according to objective analysis of clinical usage in Oriental medicine hospital: in case of stroke patients. K.O.M.S. 20(2): 37, 1999.
20. Kwon, D.I., C.N. Ko, K.H. Cho, Y.S. Kim, H.S. Bae and K.S. Lee. Clinical observation on the admitted patients of department of cardiac internal medicine of Oriental hospital. Kyung Hee Univ. Med. Center 12(2): 200-213, 1996.
21. Lyden, P., T. Brott, B. Tilley, K.M. Welch, E.J. Mascha, S. Levine, B.C. Haley, J. Grotta and J. Marler. Improved reliability of the NIH Stroke Scale using video training. Stroke 25: 2220-2226, 1994.
22. Muir, K.W., C.J. Weir, G.D. Murray, C. Povey and K.R. Lees. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 27: 1817-1820, 1996.
23. Naeser, M.A. Neurological rehabilitation: acupuncture and laser acupuncture to treat paralysis in stroke, other paralytic conditions, and pain in carpal tunnel syndrome. J. Altern. Complement. Med. 3(4): 425-428, 1997.
24. O'Mahany, P.G., R.G. Thomson, R. Dobson, H. Rodgers and O.F. James. The prevalence of stroke and associated disability. J. Public Health Med. 21(2): 166-171, 1999.
25. Popov, A.M., G.V. Malinovskaia, N.I. Uvarova, L.N. Antopkina, Iu.N. Loenko, A.A. Artiukov and G.B. Eliakov. Dokl. Akad. Nauk. 358(3): 413-415, 1998.
26. Shiflett, S. Acupuncture in stroke patients. Forsch. Komplementar. Med. 6(5): 274-276, 1999.
27. Shimizu, M., T. Matsuzawa, S. Suzuki, M. Yoshizaki and N. Morita. Evaluation of angelicae radix (Touki) by the inhibitory effect on platelet aggregation. Chem. Pharm. Bull. (Tokyo) 39(8): 2046-2048, 1991.
28. Sulter, G., C. Steen and J. De Keyser. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 30(8): 1538-1541, 1999.
29. Tian, J., H. Du, H. Yang, X. Liu and Z. Li. A clinical study on compound da huang (radix et Rhizoma rhei) preparations for improvement of senile persons' memory ability. J. Trad. Chin. Med. 17(3): 168-173, 1997.
30. Young, S.B. Experimental studies on the effects of Taeumin Chungpaesagan-tang. J. Four Constit. Assoc. 2(1): 135, 1990.